Reply to "As-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function"

Affiliations

• ¹ The Woolcock Institute of Medical Research and The University of Sydney, Sydney, Australia. Electronic address: helen.reddel@sydney.edu.au.
• ² Firestone Institute for Respiratory Health, St. Joseph's Healthcare and Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ont, Canada.
• ³ The Centre for Lung Health, Vancouver Coastal Health Research Institute and the University of British Columbia, Vancouver, BC, Canada.
• ⁴ Airway Disease Section, National Heart and Lung Institute, Imperial College, London, UK.
• ⁵ State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
• ⁶ BioPharmaceuticals R&D, Late-Stage Development, Respiratory and Immunology, AstraZeneca, Gothenburg, Sweden.
• ⁷ BioPharmaceuticals R&D, Late-Stage Development, Respiratory and Immunology, AstraZeneca, Barcelona, Spain.
• ⁸ BioPharmaceuticals R&D, Late-Stage Development, Respiratory and Immunology, AstraZeneca, Gaithersburg, Md.
• ⁹ Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa.